IL6 and cancer: Notably, the combination of IL-6 < 185 pg/mL and IL-10 < 20 pg/mL identified low-risk patients with a septic shock rate of only 0.7%, suggesting clinical utility for risk stratification in febrile pediatric cancer patients.